GoldsteinECitronDMPerainoV, et al.Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009;53:5122–5126.
2.
NicolauDPCarmeliYCrankCW, et al.Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence. Int J Antimicrob Agents. 2012;39(1):11–15.
3.
YoonYKYangKSLeeSE, et al.Effects of Group 1 versus Group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems: a before and after intervention study of carbapenem-use stewardship. PLoS One. 2014;9(6):e99101.
4.
Gomez-ZorrillaSCamoezMTubauF, et al.Antibiotic pressure is a major risk factor for rectal colonization by multidrug-resistant Pseudomonas aeruginosa in critically ill patients. Antimicrob Agents Chemother. 2014;58(10):5863–5870.
5.
ATC/DDD Index 2015 [Internet]. Oslo, Norway: World Health Organization Collaborating Centre for Drug Statistics Methodology; 2013. http://www.whocc.no/atc_ddd_index/. Accessed January 23, 2018.
6.
BhargavaAHayakawaKSilvermanE, et al.Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol. 2014;35(4):398–405.
7.
GuptaNLimbagoBMPatelJB, et al.Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53(1):60–67.
